Regular physical activity after weight loss offers greater cardiovascular protection than glp-1 medications, reducing inflammation and improving arterial health to lower heart attack and stroke risks.

Emerging research suggests that semaglutide, a GLP-1 receptor agonist, may protect against diabetic retinopathy by reducing oxidative stress and promoting retinal cell repair. This could lead to new treatments for preventing vision loss in diabetics.

A recent UK study reveals that problem gambling significantly increases the risk of suicide among young people, highlighting the urgent need for preventive measures to address gambling harms and mental health support.

A federal vaccine advisory panel is considering a controversial recommendation to delay hepatitis B vaccination from birth to age four, raising concerns over potential increases in early childhood infection and long-term health risks.

New drug combinations for melanoma resistant to immunotherapy show promise in reactivating the immune system and improving treatment outcomes. Based on research from Sutter Health, these findings pave the way for upcoming clinical trials and personalized therapies.

Research reveals that IL-10, a small immune protein produced by lung macrophages, plays a key role in preventing inflammation-driven lung diseases such as pulmonary fibrosis. Understanding IL-10 signaling may lead to new treatments for chronic lung conditions.

New research reveals pain-sensing nerve cells play a crucial role in protecting the lungs from scarring, opening potential new treatments for pulmonary fibrosis.

Stanford researchers have developed CRISPR-GPT, an AI tool that simplifies gene editing design, accelerating the development of gene therapies and making genome editing more accessible across various industries.

New research indicates that riluzole, a drug used for motor neuron diseases, may significantly improve recovery outcomes when administered early after spinal cord injury, offering new hope for patients and clinicians alike.

A novel surgical technique combining vision preservation with targeted radiation therapy may significantly reduce metastasis and improve survival in patients with uveal melanoma, offering new hope for this rare eye cancer.